A new tool to help oncology practitioners working across all settings to develop their own survivorship care plans (SCPs) was unveiled today, and the experts who have worked hard to develop it hope that it will make the process less time-consuming and more straightforward for the nation's 14.5 million survivors and the healthcare providers who treat them.
Patients with certain lung and colorectal cancers whose physicians participated in weekly, treatment-focused tumor board meetings had improved survival and were 60% more likely to enroll in a clinical trial
Patients who are uninsured, nonwhite, less educated, poorer, not married, older, male, or have advanced-stage cancer have a higher mortality risk within 1 month of cancer surgery
A new study has found that parents with dependent children are more likely to pursue life-extending treatments in order to have more time with their children.
Even though breast cancer predominantly affects white women, breast cancer outcomes are worse among black women. But a new study suggests that enrollment in a federal program may help reduce racial disparities among these patients.
Katherine Morris, MD, had only been practicing for 3 years when Cody Curtis asked her to prescribe lethal medication so that she could die on her own terms.
The FDA has approved NEPA (Akynzeo) to treat nausea and vomiting in patients undergoing chemotherapy as part of their cancer treatment.
Dellann Elliott Mydland, founder and president of the Pacific Northwest–based Chris Elliott Fund travels widely, including to the nation's capital, to advocate on behalf of brain tumor patients across the United States.
Only 10% of breast cancer is hereditary. Which means 90% is not. Now, you can't change your genes, but healthier lifestyle choices can make a difference.
A new study has found that nearly one third of cancer patients suffer from anxiety or other mental health challenges, with breast cancer patients, head and neck cancer patients and melanoma patients suffering the most.
A number of practices are grappling with how to implement meaningful use objectives, including patients' access to their medical records.
A new study has found that obesity and high inflammation during adolescence was associated with an increased risk of developing colorectal cancer later in life
The Screen This Too! campaign, created by the Colon Cancer Alliance, expands the awareness and prevention conversation. Simple in concept, broad in scope – this campaign encourages you to not only think pink during October, but to consider your colon too.
Getting trusted, helpful information about cutaneous lymphoma can be a challenge. Whether you're a patient, loved one, medical professional or supporter of our work, you've been touched by cutaneous lymphoma.
Michael J. Hennessy Associates‚ Inc (MJH), a full-service healthcare education, market research, and communications company reaching more than 600,000 healthcare professionals, has acquired CURE Media Group (www.curetoday.com) from McKesson Specialty Health, a division of McKesson Corporation.
The Sarcoma Foundation of America (SFA), a 501(c)(3) nonprofit charitable organization, advocates for increased research to find new and better therapies with which to treat patients with sarcoma
New research suggests that exposure to dim light at night may cause breast cancer patients to become resistant to certain types of therapy.
The Prostate Cancer Foundation (PCF) has awarded 27 new Young Investigator Award selected from 16 countries to advance new drug discovery, immunotherapy, nutritional sciences, and diagnostics for precision medicine.
New research on the risk-reducing benefits of aspirin shed more light on its mechanism of action as well as its potential benefit to reduce the risk of aggressive prostate cancer
Researchers at Dana-Farber Cancer Institute noted that a number of survivorship care recommendations and templates for care plans exit but little is known about patients' preferences in survivorship care planning.
Patients in one phase III trial gained 2.4 pounds of lean body mass during 12 weeks of treatment with anamorelin, and those in the second trial had an average increase in lean body mass of 1.65 pounds.
FORCE is hosting two informative webinars in October for people affected by hereditary breast and ovarian cancer.
Academic medical centers and commercial genetics laboratories across the country have joined forces to establish the Prospective Registry Of Multi-Plex Testing (PROMPT), an online registry for individuals and families who have undergone testing for inherited cancer-causing genetic mutations.
The flu might just be an unwelcome nuisance for the average individual, but it can cause serious complications for cancer patients receiving treatment.
Lung cancer at any age is a catastrophic illness but it is particularly devastating when it affects young adults in the prime of their life.
Two active maintenance regimens following disease stabilization with standard induction therapy demonstrated superior disease-free outcomes compared with no treatment in patients with metastatic colorectal cancer
Many studies have found a link between regular exercise and a lower risk of being diagnosed with breast cancer or breast cancer coming back (recurrence). As a result, the American Cancer Society and many doctors recommend that women who've been diagnosed with breast cancer, as well as those who haven't, exercise regularly – about 4 to 5 hours per week at a moderate intensity level. (Brisk walking is considered moderate intensity exercise.)
Facing Our Risk of Cancer Empowered (FORCE), the nation's only nonprofit organization dedicated to families with hereditary breast and ovarian cancer (HBOC), is celebrating National Hereditary Breast and Ovarian Cancer Week and National Previvor Day to create awareness and recognize those affected by a genetic predisposition to these cancers.
A new study has confirmed that e-cigarettes are doing more harm than good when it comes to helping cancer patients quit smoking.
To address the question of whether axillary dissection is necessary in older women, researchers in Milan, Italy recruited 238 women aged 65-80 years with cT1cN0 breast cancer and randomized them to receive conservative surgery with or without axillary node dissection.
